BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 28705621)

  • 1. Functionalized PLA-PEG nanoparticles targeting intestinal transporter PepT1 for oral delivery of acyclovir.
    Gourdon B; Chemin C; Moreau A; Arnauld T; Baumy P; Cisternino S; Péan JM; Declèves X
    Int J Pharm; 2017 Aug; 529(1-2):357-370. PubMed ID: 28705621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of PLA-PEG nanoparticles manufacturing process on intestinal transporter PepT1 targeting and oxytocin transport.
    Gourdon B; Chemin C; Moreau A; Arnauld T; Delbos JM; Péan JM; Declèves X
    Eur J Pharm Biopharm; 2018 Aug; 129():122-133. PubMed ID: 29803721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy.
    Du Y; Tian C; Wang M; Huang D; Wei W; Liu Y; Li L; Sun B; Kou L; Kan Q; Liu K; Luo C; Sun J; He Z
    Drug Deliv; 2018 Nov; 25(1):1403-1413. PubMed ID: 29890854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
    Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
    Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiodipeptides targeting the intestinal oligopeptide transporter as a general approach to improving oral drug delivery.
    Foley DW; Pathak RB; Phillips TR; Wilson GL; Bailey PD; Pieri M; Senan A; Meredith D
    Eur J Med Chem; 2018 Aug; 156():180-189. PubMed ID: 30006163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of peptide transporter 1 in the intestinal permeability of valacyclovir in wild-type and PepT1 knockout mice.
    Yang B; Smith DE
    Drug Metab Dispos; 2013 Mar; 41(3):608-14. PubMed ID: 23264448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal absorption and activation of decitabine amino acid ester prodrugs mediated by peptide transporter PEPT1 and enterocyte enzymes.
    Tao W; Zhao D; Sun M; Wang Z; Lin B; Bao Y; Li Y; He Z; Sun Y; Sun J
    Int J Pharm; 2018 Apr; 541(1-2):64-71. PubMed ID: 29471144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of peptide transporter 1 on the intestinal absorption and pharmacokinetics of valacyclovir after oral dose escalation in wild-type and PepT1 knockout mice.
    Yang B; Hu Y; Smith DE
    Drug Metab Dispos; 2013 Oct; 41(10):1867-74. PubMed ID: 23924683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1.
    Pak YA; Long AJ; Annes WF; Witcher JW; Knadler MP; Ayan-Oshodi MA; Mitchell MI; Leese P; Hillgren KM
    Drug Metab Dispos; 2017 Feb; 45(2):137-144. PubMed ID: 27895114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Absorption Analysis of Valacyclovir in Wildtype and Pept1 Knockout Mice Following Oral Dose Escalation.
    Yang B; Smith DE
    Pharm Res; 2017 Nov; 34(11):2349-2361. PubMed ID: 28770489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A physiologically based pharmacokinetic model for valacyclovir established based on absolute expression quantity of hPEPT1 and its application.
    Sun L; Wang C; Zhang Y
    Eur J Pharm Sci; 2018 Oct; 123():560-568. PubMed ID: 30081070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclovir prodrug for the intestinal di/tri-peptide transporter PEPT1: comparison of in vivo bioavailability in rats and transport in Caco-2 cells.
    Thomsen AE; Christensen MS; Bagger MA; Steffansen B
    Eur J Pharm Sci; 2004 Dec; 23(4-5):319-25. PubMed ID: 15567284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
    Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
    Cao F; Gao Y; Wang M; Fang L; Ping Q
    Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
    Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
    Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the intestinal and oral absorption of the prodrug valacyclovir in wildtype and huPepT1 transgenic mice.
    Epling D; Hu Y; Smith DE
    Biochem Pharmacol; 2018 Sep; 155():1-7. PubMed ID: 29935147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
    Anand BS; Patel J; Mitra AK
    J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.
    Ganapathy ME; Huang W; Wang H; Ganapathy V; Leibach FH
    Biochem Biophys Res Commun; 1998 May; 246(2):470-5. PubMed ID: 9610386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical determinant of intestinal permeability and oral bioavailability of pegylated all trans-retinoic acid prodrug-based nanomicelles: Chain length of poly (ethylene glycol) corona.
    Li Z; Han X; Zhai Y; Lian H; Zhang D; Zhang W; Wang Y; He Z; Liu Z; Sun J
    Colloids Surf B Biointerfaces; 2015 Jun; 130():133-40. PubMed ID: 25907597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.